MedTrace Logo

SONICS - Effectiveness of Specialist Oncology Nursing

NCT00182234 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 183

Last updated 2009-06-18

No results posted yet for this study

Summary

This research project will address the issue of gaps in continuity of supportive care for cancer patients during the early phases of the disease trajectory that result in unmet needs and unnecessary morbidity. The investigators intend to study the impact of a specialized cancer-nursing program, Interlink Community Cancer Nurses (Interlink) on patient outcomes. Impact will be assessed directly using a validated measure of continuity of care from the patients' perspective and validated measures of key supportive care patient outcomes including unmet needs, distress, uncertainty in illness, and quality of life, in a randomized trial.

Conditions

  • Continuity of Care
  • Quality of Life

Interventions

BEHAVIORAL

Community Interlink Program

The study intervention is a referral to a specialized oncology nursing program. The standardized care provided by this program includes comprehensive assessment and care planning specific to breast and colorectal cancers during the initial phases of treatment, with a minimum of two home visits. Through consultation with the patient, nurses either provide direct (non-medical) care to address needs identified and/or coordinate linkage to services in the community.

Sponsors & Collaborators

  • McMaster University

    lead OTHER

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • Ontario Ministry of Health and Long Term Care

    collaborator OTHER_GOV

Principal Investigators

  • Jonathan Sussman, MD, CCFP, FRCP (c), MSc · Supportive Cancer Care Research Unit

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2009-03-31
Completion
2009-03-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00182234 on ClinicalTrials.gov